CompletedNot Applicable

B-TURP vs BipolEP in Management of BPH Patients With Medium-sized Prostates

Egypt63 participantsStarted 2022-07-01

Plain-language summary

This is a comparative study of the efficacy and safety of endoscopic bipolar transurethral resection and enucleation of the prostate in management of benign prostatic hyperplasia patients with medium-sized prostates

Who can participate

Age range45 Years – 80 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male patients aged 45-80 years with symptomatic BPH (IPSS ≥8). * Prostate volume between 40-80 cc as determined by transrectal ultrasound (TRUS). * Failure of medical management. * Written informed consent. Exclusion Criteria: * Prostate cancer (suspected on PSA/DRE or confirmed by biopsy). * Previous prostate/urethral surgery. * Neurogenic bladder or urethral strictures. * Significant coagulopathy. * Uncontrolled urinary tract infection. * Patient on anticoagulant medication.

What they're measuring

Change in international prostate symptom score (IPSS)

Timeframe: At 6 months after the procedure (BipolEP or B-TURP)

Trial details

NCT IDNCT06939062

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-01

View on ClinicalTrials.gov More Benign Prostatic Hyperplasia trials